Hadjinor, Darwisa .
HRN: 21-10-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/17/2023
IVT
1.5 Gm
On Call To OR ANST
Repeat STAT CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes